- Poster presentation
- Open Access
The extent of myocardium at risk for LAD, RCA and LCx using contrast enhanced SSFP and T2-weighted imaging
© Nordlund et al; licensee BioMed Central Ltd. 2015
- Published: 3 February 2015
- Acute Myocardial Infarction
- Cardiovascular Magnetic Resonance
- Late Gadolinium Enhancement
- Myocardial Perfusion SPECT
- Recovery Imaging
Contrast enhanced SSFP (CE-SSFP) and T2-weighted triple inversion recovery imaging (T2w) have both been clinically validated for determining myocardium at risk (MaR) by cardiovascular magnetic resonance (CMR), using myocardial perfusion SPECT (MPS) as reference standard. Previously, MPS has been used to describe the coronary perfusion territories during myocardial ischemia. Compared to MPS, CMR offers superior image quality and logistical advantages. The aim of this study was to describe the coronary perfusion territories of LAD, RCA and LCx based on CMR data using CE-SSFP and T2w in patients after ST-elevation myocardial infarction.
CE-SSFP and T2w data from the recently published international multi-center trials CHILL-MI and MITOCARE, was used to assess MaR. CE-SSFP images from 206/212 patients (6 excluded due to inability to detect MaR) and T2w images from 147/212 patients (12 excluded due to missing data, 53 due to inability to detect MaR) were included. Late gadolinium enhancement (LGE) imaging was used to assess infarct size. Imaging was performed on systems from three different vendors (Siemens, Philips, GE) and data was analyzed by a core laboratory. Culprit vessel was determined using angiography.
The perfusion territories of the three main coronary arteries were described using CE-SSFP and T2w in patients with acute myocardial infarction and resemble previous territories by MPS, with expected overlap between RCA and LCx.
- Pereztol-Valdés : Correspondence between left ventricular 17 myocardial segments and coronary arteries. Eur Heart J. 2005, 26 (24): 2637-2643. 10.1093/eurheartj/ehi496.View ArticlePubMedGoogle Scholar
- Persson : Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion. Nucl Med Commun. 2002, 23 (3): 219-228. 10.1097/00006231-200203000-00004.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.